Svetlana A. Berns

Moscow, MOW, RU 
Moscow, MOW, RU 

Overview

Svetlana Berns practices practicing medicine in Moscow, Russian Federation.

Her clinical expertise encompasses Acute Coronary Syndrome, Unstable Angina, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

She is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Moscow, MOW, Russian Federation
Other Locations
Russian Federation
Kemerovo, KEM, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Enrollment Status: Completed
Publish Date: January 06, 2025
Intervention Type: Drug
Study Phase: Phase 3
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of Ergoferon as Non-specific COVID-19 Prevention During Vaccination Against SARS-CoV-2
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of Ergoferon as Non-specific COVID-19 Prevention During Vaccination Against SARS-CoV-2
Enrollment Status: Completed
Publish Date: December 05, 2024
Intervention Type: Drug
Study Drug: Ergoferon
Study Phase: Phase 3
A Multicenter, Double-blind, Placebo-controlled, Parallel-group, Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Patients With Post-COVID-19 Asthenia.
A Multicenter, Double-blind, Placebo-controlled, Parallel-group, Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Patients With Post-COVID-19 Asthenia.
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Drug
Study Drug: Prospekta
Study Phase: Phase 3
A Multicenter, Placebo-controlled, Double-blind, Randomized Clinical Trial in Parallel Groups to Evaluate the Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
A Multicenter, Placebo-controlled, Double-blind, Randomized Clinical Trial in Parallel Groups to Evaluate the Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
Enrollment Status: Suspended
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: MMH-407
Study Phase: Phase 3
Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of MMH-407 in the Treatment of Acute Respiratory Viral Infection
Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of MMH-407 in the Treatment of Acute Respiratory Viral Infection
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat Caused by URTI in Adults.
A Multi-center, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat Caused by URTI in Adults.
Enrollment Status: Completed
Publish Date: October 18, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

26 Total Publications

Comparison of thrombodynamic methods and routine hemostasis tests in the evaluation of hypercoagulable syndrome in chronic glomerulonephritis
Comparison of thrombodynamic methods and routine hemostasis tests in the evaluation of hypercoagulable syndrome in chronic glomerulonephritis
Journal: Terapevticheskii arkhiv
Published: July 06, 2024

Frequently Asked Questions about Svetlana A. Berns

Is Svetlana A. Berns a top-rated expert for Acute Coronary Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Svetlana A. Berns is classified as an Experienced expert for Acute Coronary Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Svetlana A. Berns participate in research or clinical trials?

Yes. Svetlana A. Berns has published 26 articles and abstracts on conditions like Acute Coronary Syndrome. You can view a list of Svetlana A. Berns's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Berns's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile